|
It was RiverVest Managing Director J. Gordon Foulkes’ perspicacity in shepherding pharmaceuticals from gene discovery to clinical trials that attracted entrepreneur Nicholas Dean, Ph.D., to his future business partner. More > |
|
|
Experience, steady leadership, a willingness to drive change, and a deep understanding of the growing pains of a start-up” these are a few of the benefits CEO Joe Army cites when discussing the role of Salient’s Chairman of the Board Jay Schmelter, who is also a managing director of RiverVest. More > |
|
|
What happens when a VC Fund’s managing director with interventional cardiology expertise is asked by a fellow entrepreneur with a track record of multibillion-dollar inventions to help build a company around a groundbreaking interventional cardiology device? More > |
|
